Cellectis CLLS
NASDAQ CLLS
$1.50 +0.03 (+2.38%)
As of: Sep 30, 2026 · 10:15 AM EDT

Cellectis (CLLS) Convertible Debt (2015 - 2024)

Updated

Cellectis' Convertible Debt was $138.58 million in Q4 2024, up 2.5% from $135.15 million a year earlier but down 1.7% from the prior quarter.

Analysis

Cellectis (CLLS) Convertible Debt (2015 - 2024) Analysis & Trends

From Q4 2015 onward, Cellectis has reported Convertible Debt for 6 quarters.

  • In earlier years, Convertible Debt was $135.15 million in FY2023.
  • Quarterly Convertible Debt has moved between $135.15 million (Q4 2023) and $141 million (Q3 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Cellectis 148.50 Mn -604.89 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 138.58 Mn
Sep 30, 2024 141.00 Mn
Jun 30, 2024 137.58 Mn
Dec 31, 2023 135.15 Mn
Dec 31, 2016 16.68 Mn
Dec 31, 2015 23.34 Mn
API Access

Cellectis Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=CLLS&period=max&api_key=YOUR_API_KEY